{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:18:51Z","timestamp":1792729131797,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pdpdt.2021.102179","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T14:06:52Z","timestamp":1610460412000},"page":"102179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor"],"prefix":"10.1016","volume":"33","author":[{"given":"Jimpei","family":"Miyakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-2874","authenticated-orcid":false,"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2021.102179_bib0005","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: randomized two centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0010","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/01.ju.0000181814.73466.14","article-title":"Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study","volume":"174","author":"Daniltchenko","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.urology.2006.10.015","article-title":"Seven years\u2019 experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder","volume":"69","author":"Hungerhuber","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pdpdt.2015.03.008","article-title":"Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a randomized, double-blaind, multicentre phase II\/III study","volume":"12","author":"Inoue","year":"2015","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/iju.13718","article-title":"Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: a multicenter phase III study","volume":"25","author":"Nakai","year":"2018","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0035","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/iju.14099","article-title":"Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer","volume":"26","author":"Nohara","year":"2019","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pdpdt.2013.03.007","article-title":"Risk factors for developing oral 5-aminolevulinic acid-induced side effects in patients undergoing fluorescence guided resection","volume":"10","author":"Chung","year":"2013","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40981-020-00340-9","article-title":"Identification of risk factors for post-induction hypotention in patients receiving 5-aminolevulinic acid: a single-center retrospective study","volume":"6","author":"Yatabe","year":"2020","journal-title":"JA Clin. Rep."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1213\/XAA.0000000000001128","article-title":"Severe and prolonged hypotension after oral 5-aminolevulinic acid administration in a patient with end-stage renal disease undergoing transurethral resection of a bladder tumor: a case report","volume":"14","author":"Kida","year":"2020","journal-title":"A A Pract."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40981-019-0295-1","article-title":"Preanesthetic severe postural hypotension following 5-aminolevulinic acid pretreatement in patients for photodynamic diagnosis-assisted urological surgery","volume":"5","author":"Shiratori","year":"2019","journal-title":"JA Clin Rep."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40981-019-0279-1","article-title":"5-Aminolevulinic acid-inducecd severe hypotension during transurethral resection of a bladder tumor: a case report","volume":"5","author":"Yatabe","year":"2019","journal-title":"JA Clin. Rep."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0065","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0075","series-title":"Regional Office for the Western Pacific. The Asia-pacific Perspective: Redefining Obesity and Its Treatment","author":"World Health Organization","year":"2000"},{"issue":"3","key":"10.1016\/j.pdpdt.2021.102179_bib0080","first-page":"1","article-title":"Clinical practice guideline for the evaluation and management of chronic kidney disease","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO 2012","year":"2013","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-5347(01)63932-6","article-title":"Early clinical experience with 5-aminolevulinic acid for the photodyanmic therapy of upper tract urothelial tumores","volume":"159","author":"Waidelich","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pdpdt.2012.06.004","article-title":"Oral 5-aminolevulinic acid induced Photodynamic Diagnostic Ureterorenoscopy\u2014dose the blood pressure require monitoring?","volume":"10","author":"Bondad","year":"2013","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.aju.2017.01.003","article-title":"Photodynamic diagnosis in upper urinary tract urothelial carcinoma: a systematic review","volume":"15","author":"Osman","year":"2017","journal-title":"Arab J. Urol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1011-1344(98)00086-4","article-title":"Hemodynamic effects of 5-aminolevulinic acid in humans","volume":"43","author":"Herman","year":"1998","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18773\/austprescr.2017.053","article-title":"Drug dosing in obese adults","volume":"40","author":"Barras","year":"2017","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0110","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00000542-199809000-00004","article-title":"Remifentanil pharmacokinetics in obese versus lean patients","volume":"89","author":"Egan","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-85-2-183","article-title":"Gentamicin serum concentrations: pharmacokinetic predictions","volume":"85","author":"Hull","year":"1976","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl 23","key":"10.1016\/j.pdpdt.2021.102179_bib0125","first-page":"2","article-title":"Pharmacokinetics of drugs in the elderly","volume":"87","author":"Woodhouse","year":"1994","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0130","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0531-5565(03)00133-5","article-title":"When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly","volume":"38","author":"Turnheim","year":"2003","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1011-1344(98)00102-X","article-title":"5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration","volume":"44","author":"van den Boogert","year":"1998","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.pdpdt.2021.102179_bib0140","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.301.2.507","article-title":"Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer","volume":"301","author":"Dalton","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pdpdt.2021.102179_bib0145","series-title":"Common Toxicity Criteria for Adverse Events (CTCAE) v5.0","author":"National Cancer Institute Cancere Therapy Evaluation Program (CTEP)","year":"2017"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:38:46Z","timestamp":1761611926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":29,"alternative-id":["S1572100021000053"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102179","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of age, body mass index, and renal function for severe hypotension caused by oral 5-aminolevulinic acid administration in patients undergoing transurethral resection of bladder tumor","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102179"}}